Minn. legislators to FDA: Don't tread on device makers

May 28, 2010 by MedCity News

Sen. Amy Klobuchar (D:Minn.) and Rep. Erik Paulsen (R:Minn.) urge the Food & Drug Administration to go easy on proposed changes to the 510(k) program.

MedCity News logo

A pair of Minnesota legislators are lobbying against changes the Food & Drug Administration proposes for its 510(k) clearance protocol the industry says will hurt innovation and the state’s economy.

U.S. Sen. Amy Klobuchar (D:Minn.) and Rep. Erik Paulsen (R:Minn.) sent a letter to FDA Commissioner Dr. Margaret Hamburg, warning that overzealous regulation would hurt start-ups struggling to raise venture capital in a weak economy.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.